|
D-(−)-Arabinose 10323-20-3
L-(+)-Arabinose 5328-37-0
2-Deoxy-D-r...
|
2010-04-15
|
Galacitol
|
|
|
Product Name: Galantamine hydrobromide
CAS Registry Number: 1953-04-4
S...
|
2008-09-17
|
Galantamine hydrobromide
|
|
|
Galanthamine is an effective, competitive and reversible acetylcholin ester...
|
2008-10-21
|
Galantamine hydrobromide
|
|
|
Pharmaceuticals, nutraceuticals
|
2005-08-13
|
C17H21NO3
|
|
|
Usage: For nervous system diseases and trauma caused by movement disorders,...
|
2013-01-24
|
Galanthamine hydrobromide
|
|
|
Where will be Galanthamine Hydrobromide use to ?
• Anesthesiology
...
|
2007-06-09
|
Galanthamine Hydrobromide
|
|
|
Galanthamine extract is applicable in medical practice wherever there is a ...
|
2003-06-05
|
|
|
Chemical Name: GALANTHAMINONE
Molecular Formula: C17H19NO3
Formula Weig...
|
2012-11-07
|
GALANTHAMINONE 95%
|
|
|
origin: growing alongside forest,road side ,field,shrub,and meadow in Hulun...
|
2008-03-22
|
Galeopsis bifida extract
|
|
|
Producing area : Roadside and wild slope.Produces in HuLunBeiEr,Inner Mongo...
|
2008-03-22
|
Galinsoga parviflora extract
|
|
|
Producing area : Mountainous region or edge of forest or Under forest and b...
|
2008-03-22
|
Galium spurium extract
|
|
|
galiximab cas 357613-77-5
|
2007-10-16
|
galiximab cas 357613-77-5
|
|
|
Pharmaceuticals, nutraceuticals
|
2005-08-13
|
C7H6O5
|
|
|
Gallic acid acts as a antioxidant and helps to protect our cells against ox...
|
2009-12-04
|
C7H6O5
|
|
|
pharmaceutical ingredient
|
2012-05-24
|
C7H6O5,99%,odorless white solid
|
|
|
Industrial gallic acid used in analyzing and testing bismuth, cerium, cop...
|
2009-09-21
|
3,4,5- trihydroxybenzoic acid
|
|
|
Electronic Chemicals
|
2008-02-29
|
Gallium, tris(8-quinolinolato)-
|
|
|
Galsulfase cas 552858-79-4
|
2007-10-16
|
Galsulfase cas 552858-79-4
|
|
|
Pharmaceuticals, nutraceuticals
|
2005-08-13
|
C24H34O5
|
|
|
Pharmaceuticals, nutraceuticals
|
2005-08-13
|
C23H28O6
|
|
|
gamithromycin 145435-72-9
|
2007-05-10
|
gamithromycin 145435-72-9
|
|
|
Applications:
1) Used to produce a-pyrrolidone, 1-Methyl-2-pyrrolidinone, ...
|
2014-09-15
|
Gamma Butyrolactone
|
|
|
Pharmaceutical Use
|
2012-12-21
|
Gamma-Aminobutyric Acid 56-12-2
|
|
|
Flavor Enhancers
|
2015-01-08
|
Clear colorless oily liquid with a pleasant odor.
|
|
|
Uses:
(1) GBL can be used to produce a-pyrrolidone, 1-Methyl-2-pyrrolidino...
|
2015-08-25
|
Colourless oily liquid
|
|
|
Intermediate in synth of polyvinylpyrrolidone, dl-methionine, piperidine, p...
|
2011-04-19
|
gamma-Butyrolactone ЎГ99.8%
|
|
|
¦Г-butyrolactone is an important organic synthetic raw material and a fine
|
2008-04-30
|
Gamma-butyrolactone
|
|
|
Pharmaceutical Use
|
2012-12-21
|
Gamma-Cyclodextrin
|
|
|
Gamma-Cyclodextrin
Feature:
Gamma-Cyclodextrin is a ring-shaped molecule...
|
2012-12-17
|
Gamma-Cyclodextrin
|
|
|
Pharmaceutical Use
|
2012-12-21
|
Gamma-Cyclodextrin 17465-86-0
|
|
|
Gamma-Nonanolactone
CAS No.: 104-61-0
Molecular Weight 156.22
Molecul...
|
2012-12-17
|
Gamma-Nonanolactone
|
|
|
It is used in pharmaceutical and cosmetic
|
2013-02-04
|
C40H58O4 99%
|
|
|
Usage: For periodic mental illness, premenstrual stress disorder, climacter...
|
2013-01-24
|
gamma-Oryzanol
|
|
|
gamma-Oryzanol
Appearance White or almost white powder ,odorless
Assay 97...
|
2013-04-08
|
Appearance White or almost white powder ,odorless
|
|
|
pharmaceutical raw material ,intermediates
|
2015-01-08
|
White to off-white crystalline powder
|
|
|
For periodic psychosis, premenstrual stress disorder, menopause syndrome, v...
|
2013-05-07
|
gamma-Oryzanol (CAS No.:11042-64-1)
|
|
|
Molecular formula: C9H13N5O4
Molecular weight: 255.23
Standard:CP2005
...
|
2007-04-18
|
2-Amino-1,9-((2-hydroxy-1-(hydroxy methyl)ethoxy)methyl)-6H-purin-6-one
|
|
|
bulk drug for antiviral
|
2010-04-08
|
Ganciclovir [82410-32-0]
|
|
|
Product Name: Ganoderma Extract
Latin Name:Ganoderma lucidum (Leyss.: Fr.)...
|
2011-02-28
|
Ganoderma lucidum Polysaccharide
|
|
|
Ganoderma is a treasure trove of treasures motherland Chinese medicine, kno...
|
2007-08-08
|
ganoderma extract
|
|
|